Thr236

Site Information
CkKYMRktCGDVLDN SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 25311881

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	leukemia ( 2 ) , chronic myelogenous leukemia ( 2 ) , lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	K562 (erythroid) ( 2 ) , NCI-H3255 (pulmonary) ( 1 )

References
1	Moritz A (2007) CST Curation Set: 2746; Year: 2007; Biosample/Treatment: cell line, NCI-H3255/-; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXT-P) (81E12B5) Rabbit mAb Cat#: 10003 Curated Info
2	Moritz A (2007) CST Curation Set: 2747; Year: 2007; Biosample/Treatment: cell line, K562/-; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXT-P) (81E12B5) Rabbit mAb Cat#: 10003 Curated Info